{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:07:27Z","timestamp":1773281247756,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,4,25]],"date-time":"2009-04-25T00:00:00Z","timestamp":1240617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00347-009-1934-0","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T17:08:20Z","timestamp":1240506500000},"page":"399-406","source":"Crossref","is-referenced-by-count":12,"title":["Topische antiangiogene Therapie an der Hornhaut","Topical inhibition of angiogenesis at the cornea"],"prefix":"10.1007","volume":"106","author":[{"given":"B.","family":"Regenfuss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,25]]},"reference":[{"key":"1934_CR1","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","volume":"103","author":"Cursiefen","year":"2006","unstructured":"Cursiefen C, Chen L, Saint-Geniez M et al (2006) Nonvascular VEGFR3 expression by corneal epithelium maintains avascularity and vision. Proc National Acad Sci USA 103:11405\u201311410","journal-title":"Proc National Acad Sci USA"},{"key":"1934_CR2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000099253","volume":"92","author":"Cursiefen","year":"2007","unstructured":"Cursiefen C (2007) Immune privilege and angiogenic privilege in the cornea. In: Niederkorn J, Kaplan HJ (eds) Immune response and the eye. Chem Immunol Allergy 92:50\u201357","journal-title":"Chem Immunol Allergy"},{"key":"1934_CR3","doi-asserted-by":"crossref","unstructured":"Cursiefen C, Kruse FE (2006) New aspects of corneal angiogenesis. In: Reinhard T, Larkin F (ed) Cornea and external eye. In Krieglstein GK, Weinreb RN: Essentials in Ophthalmology. Springer, New York 83\u201399","DOI":"10.1007\/3-540-31226-9_7"},{"key":"1934_CR4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1167\/iovs.03-0940","volume":"45","author":"Cursiefen","year":"2004","unstructured":"Cursiefen C, Masli S, Ng TF et al (2004) Roles of thrombospondin 1 and 2 in regulating spontaneous and induced angiogenesis in the cornea and iris. Invest Ophthalmol Vis Sci 45:1117\u20131124","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1934_CR5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","volume":"443","author":"Ambati","year":"2006","unstructured":"Ambati BK, Nozaki M, Singh N et al (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443:993\u2013997","journal-title":"Nature"},{"key":"1934_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00347-003-0798-y","volume":"100","author":"Cursiefen","year":"2003","unstructured":"Cursiefen C, Seitz B, Dana MR,Streilein JW (2003) Angiogenese und Lymphangiogenese in der Hornhaut: Pathogenese, Klinik und Therapieoptionen. Ophthalmologe 100:292\u2013299","journal-title":"Ophthalmologe"},{"key":"1934_CR7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00347-007-1512-2","volume":"104","author":"Bock","year":"2007","unstructured":"Bock F, Koenig Y, Dietrich T et al (2007) Inhibition of angiogenesis in the anterior chamber of the eye. Ophthalmologe 104:336\u2013344","journal-title":"Ophthalmologe"},{"key":"1934_CR8","first-page":"2127","volume":"43","author":"Cursiefen","year":"2002","unstructured":"Cursiefen C, Schl\u00f6tzer-Schrehardt U, K\u00fcchle M et al (2002) Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and Podoplanin. Invest Ophthalmol Vis Sci 43:2127\u20132135","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1934_CR9","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"Cursiefen","year":"2004","unstructured":"Cursiefen C, Maruyama K, Liu Y et al (2004) Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 45:2666\u20132673","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1934_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","volume":"126","author":"Bachmann","year":"2008","unstructured":"Bachmann B, Bock F, Wiegand S et al (2008) VEGF-A-neutralization after high-risk corneal transplantation promotes graft survival. Arch Ophthalmol 126:71\u201377","journal-title":"Arch Ophthalmol"},{"key":"1934_CR11","unstructured":"Bachmann B, Bock F, Wiegand S et al (2009) Transient VEGF-A-neutralization in corneas with party regressed vessels promotes graft survival. Br J Ophthalmol. (in press)"},{"key":"1934_CR12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nm1078","volume":"10","author":"Chen","year":"2004","unstructured":"Chen L, Hamrah P, Cursiefen C et al (2004) Vascular endothelial growth factor receptor-3 (VEGFR-3) mediates dendritic cell migration to lymph nodes and induction of immunity to corneal transplants. Nat Med 10:813\u2013815","journal-title":"Nat Med"},{"key":"1934_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00003226-200304000-00021","volume":"22","author":"Cursiefen","year":"2003","unstructured":"Cursiefen C, Chen L, Dana MR, Streilein JW (2003) Corneal lymphangiogenesis: Evidence, mechanisms and implications for transplant immunology. Cornea 22:273\u2013281","journal-title":"Cornea"},{"key":"1934_CR14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00003226-200210000-00003","volume":"21","author":"Cursiefen","year":"2002","unstructured":"Cursiefen C, Martus P, Nguyen NX et al (2002) Corneal neovascularization after nonmechanical versus mechanical corneal trephination for non-high-risk keratoplasty. Cornea 21:648\u2013652","journal-title":"Cornea"},{"key":"1934_CR15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s004170100313","volume":"239","author":"Cursiefen","year":"2001","unstructured":"Cursiefen C, Wenkel H, Martus P et al (2001) Peripheral corneal neovascularization after non-high risk-keratoplasty: influence of short- versus longtime topical steroids. Graefes Arch Clin Exp Ophthalmol 239:514\u2013521","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1934_CR16","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","volume":"48","author":"Bock","year":"2007","unstructured":"Bock F, Onderka J, Dietrich T et al (2007) Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci 48:2545\u20132552","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1934_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","volume":"246","author":"Bock","year":"2008","unstructured":"Bock F, K\u00f6nig Y, Kruse FE et al (2008) Bevacizumab (Avastin\u00ae) eye drops inhibit corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol 246:281\u2013284","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1934_CR18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.exer.2008.07.013","volume":"87","author":"Hos","year":"2008","unstructured":"Hos D, Bachmann B, Bock F et al (2008) Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis. Exp Eye Res 87:427\u2013432","journal-title":"Exp Eye Res"},{"key":"1934_CR19","doi-asserted-by":"crossref","unstructured":"Bock F, Onderka J, Rummelt C et al (2009) Safety profile of topical VEGF-neutralization at the cornea. Invest Ophthalmol Vis Sci. Epub ahead of print","DOI":"10.1167\/iovs.07-1129"},{"key":"1934_CR20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exer.2008.08.007","volume":"87","author":"Bock","year":"2008","unstructured":"Bock F, Onderka J, Hos D et al (2008) Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye Res 87:462\u2013470","journal-title":"Exp Eye Res"},{"key":"1934_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/lrb.2008.6348","volume":"6","author":"Regenfuss","year":"2008","unstructured":"Regenfuss B, Bock F, Parthasarathy A, Cursiefen C (2008) Corneal (Lymph)angiogenesis-from bedside to bench and back: A tribute to judah folkman. Lymphat Res Biol 6:191\u2013201","journal-title":"Lymphat Res Biol"},{"key":"1934_CR22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/ICO.0b013e3180de1d0a","volume":"26","author":"Yoeruek","year":"2007","unstructured":"Yoeruek E, Spitzer MS, Tatar O et al (2007) Safety profile of bevacizumab on cultured human corneal cells. Cornea 26:977\u2013982","journal-title":"Cornea"},{"key":"1934_CR23","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","volume":"115","author":"Kim","year":"2008","unstructured":"Kim SW, Ha BJ, Kim EK et al (2008) The effect of topical bevacizumab on corneal neovascularization. Ophthalmology 115:e33\u2013e38","journal-title":"Ophthalmology"},{"key":"1934_CR24","doi-asserted-by":"crossref","unstructured":"Cursiefen C, Bock F, Horn F et al (2009) GS-101 eye drops, an antisense oligonucleotide against IRS-1, inhibit corneal neovascularization: interim results of a double-blind randomized phase II trial. Ophthalmology (in revision)","DOI":"10.1016\/j.ophtha.2009.04.016"},{"key":"1934_CR25","unstructured":"Parthasarathy A, Bock F, Onderka J, Cursiefen C (2009) Lucentis eye drops inhibit inflammatory corneal hem- and lymphangiogenesis. Arch Ophthalmol (in press)"},{"key":"1934_CR26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajo.2005.08.080","volume":"141","author":"Vinh","year":"2006","unstructured":"Vinh L, Nguyen N, Martus P et al (2006) Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. Am J Ophthalmol 141:260\u2013266","journal-title":"Am J Ophthalmol"},{"key":"1934_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","volume":"87","author":"Cursiefen","year":"2003","unstructured":"Cursiefen C, Rummelt C, K\u00fcchle M, Schl\u00f6tzer-Schrehardt U (2003) Pericyte recruitment in human corneal angiogenesis. Br J Ophthalmol 87:101\u2013106","journal-title":"Br J Ophthalmol"},{"key":"1934_CR28","unstructured":"K\u00f6nig Y, Bock F, Horn F et al (2009) Combination of fine-needle diathermy and Avastin for corneal neovascularization. ARVO"},{"key":"1934_CR29","first-page":"2148","volume":"41","author":"Pillai","year":"2000","unstructured":"Pillai CT, Dua HS, Hossain P (2000) Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci 41:2148\u20132153","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1934_CR30","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1167\/iovs.07-1314","volume":"49","author":"Hos","year":"2008","unstructured":"Hos D, Bock F, Dietrich T et al (2008) Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest Ophthalmol Vis Sci 49:1836\u20131842","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1934_CR31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2353\/ajpath.2007.060896","volume":"171","author":"Dietrich","year":"2007","unstructured":"Dietrich T, Onderka J, Bock F et al (2007) Inhibition of Inflammatory Lymphangiogenesis by Integrin {alpha}5 Blockade. Am J Pathol 171:361\u2013372","journal-title":"Am J Pathol"},{"key":"1934_CR32","doi-asserted-by":"crossref","unstructured":"Cursiefen C, Kruse FE, Naumann GOH (2008) Cornea and limbus. In: GOH Naumann. Applied pathology for ophthalmic microsurgeons. Springer, New York 97\u2013130","DOI":"10.1007\/978-3-540-68366-7_5"},{"key":"1934_CR33","first-page":"2363","volume":"15","author":"Maruyama","year":"2004","unstructured":"Maruyama K, Li M, Cursiefen C et al (2004) Inflammatory lymphangiogenesis arises from CD11b+ cells. J Clin Invest 15:2363\u20132372","journal-title":"J Clin Invest"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-1934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-009-1934-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-1934-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:55Z","timestamp":1559037055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-009-1934-0"}},"subtitle":["Sicherheit und Effektivit\u00e4t","Safety and efficacy"],"short-title":[],"issued":{"date-parts":[[2009,4,25]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1007\/s00347-009-1934-0","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,25]]}}}